A retrospective study of efficacy of first-line pembrolizumab for metastatic non-small cell lung cancer patients
Latest Information Update: 13 Oct 2021
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Oct 2021 New trial record
- 14 Sep 2021 Results presented at the 2021 World Conference on Lung Cancer